- Home
- PRAX vs NWE Comparison
PRAX vs NWE Comparison
Compare PRAX & NWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- NWE
- Stock Information
- Founded
- PRAX 2015
- NWE 1923
- Country
- PRAX United States
- NWE United States
- Employees
- PRAX N/A
- NWE N/A
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- NWE Power Generation
- Sector
- PRAX Health Care
- NWE Utilities
- Exchange
- PRAX Nasdaq
- NWE Nasdaq
- Market Cap
- PRAX 4.0B
- NWE 3.5B
- IPO Year
- PRAX 2020
- NWE N/A
- Fundamental
- Price
- PRAX $178.75
- NWE $61.58
- Analyst Decision
- PRAX Strong Buy
- NWE Buy
- Analyst Count
- PRAX 13
- NWE 4
- Target Price
- PRAX $202.85
- NWE $60.25
- AVG Volume (30 Days)
- PRAX 1.4M
- NWE 331.1K
- Earning Date
- PRAX 11-07-2025
- NWE 10-29-2025
- Dividend Yield
- PRAX N/A
- NWE 4.28%
- EPS Growth
- PRAX N/A
- NWE 7.14
- EPS
- PRAX N/A
- NWE 3.67
- Revenue
- PRAX $7,765,000.00
- NWE $1,527,970,000.00
- Revenue This Year
- PRAX N/A
- NWE $5.75
- Revenue Next Year
- PRAX $20.00
- NWE $4.62
- P/E Ratio
- PRAX N/A
- NWE $16.81
- Revenue Growth
- PRAX 338.45
- NWE 3.78
- 52 Week Low
- PRAX $26.70
- NWE $50.43
- 52 Week High
- PRAX $205.89
- NWE $61.90
- Technical
- Relative Strength Index (RSI)
- PRAX 80.27
- NWE 71.03
- Support Level
- PRAX $164.75
- NWE $57.12
- Resistance Level
- PRAX $192.96
- NWE $61.90
- Average True Range (ATR)
- PRAX 11.99
- NWE 1.03
- MACD
- PRAX 13.57
- NWE 0.32
- Stochastic Oscillator
- PRAX 82.53
- NWE 94.36
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.
About NWE NorthWestern Energy Group Inc.
NorthWestern Energy Group Inc provides electricity and natural gas services in the Upper Midwest and Northwest of the U.S. in the states of Montana, South Dakota, Nebraska, and Yellowstone National Park. The company's primary segments include Electric utility operations, which include the generation, purchase, transmission, and distribution of electricity, and Natural Gas utility operations, which include the production, purchase, transmission, storage, and distribution of natural gas. The company uses thermal, wind, hydro, or renewable energy in varying quantities, depending on the location of the facilities, to generate power. The company derives the majority of its revenue from the Electric utility operations segment.